$AMBQ

Hanson Scott McLean sold $3.3M of AMBQ

Hanson Scott McLean (Chief Technology Officer) sold 55,000 shares of Ambiq Micro, Inc. (AMBQ) at an average of $59.69 ($59.58–$60.32, $3.28M total) across 3 trades over 2026-08-26 to 2026-08-27.

Original reporting
SEC EDGAR · Hanson Scott McLean
Published Aug 28, 2026, 9:19 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 9:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMBQ
Bearish
medium confidence
Mentioned
$AMBQ
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQBearishLow
01

Why it matters

The sale reduces insider ownership, which can be interpreted as a negative signal by the market.

02

Market read

Insider sell of $3.3M in a micro‑cap may prompt short‑term price weakness.

03

What to watch

No 10b5‑1 plan and insider retains a sizable position, suggesting continued confidence.

Relevance 6/10Novelty 5/10Timing: filed Aug 28 after market close

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$AMBQBearishMedium confidence
Context

CTO Hanson Scott McLean sold 55,000 shares for $3.28M, reducing his stake to 221,226 shares.

Expected impact

Possible modest decline in AMBQ price over the next few days.

Evidence & confidence

Sale size is notable for a micro‑cap, but no 10b5‑1 plan and insider remains a large holder.

Market effects

Minimal impact on the broader semiconductor sector.

Limited to U.S. micro‑cap investors.

Low

Counterpoint

Insider may be diversifying; sale does not necessarily indicate negative fundamentals.

Key entities

  • Ambiq Micro, Inc.

    Micro‑cap semiconductor company listed on Nasdaq.

  • Hanson Scott McLean

    Chief Technology Officer of Ambiq Micro.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.